BANK VONTOBEL/CALL/ELI LILLY & CO/720/0.1/20.09.24 Share Price

Warrant

DE000VM3XQP8

Market Closed - Deutsche Boerse AG 11:32:38 14/06/2024 pm IST
16.41 EUR +0.43% Intraday chart for BANK VONTOBEL/CALL/ELI LILLY & CO/720/0.1/20.09.24
Current month+45.87%
1 month+115.07%
Date Price Change
14/24/14 16.41 +0.43%
13/24/13 16.34 +9.22%
12/24/12 14.96 -0.20%
11/24/11 14.99 +0.33%
10/24/10 14.94 +4.62%

Delayed Quote Deutsche Boerse AG

Last update June 14, 2024 at 11:32 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer Vontobel Vontobel
WKN VM3XQP
ISINDE000VM3XQP8
Date issued 12/10/2023
Strike 720 $
Maturity 20/09/2024 (96 Days)
Parity 10 : 1
Emission price 3.95
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 17.23
Lowest since issue 2.05
Delta0.91x
Omega 4.565
Premium1.83x
Gearing5.03x
Moneyness 1.220
Difference Strike -158.5 $
Difference Strike %-22.01%
Spread 0.02
Spread %0.12%
Intrinsic value 14.80

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
878.4 USD
Average target price
855.4 USD
Spread / Average Target
-2.63%
Consensus